(SECT-B) Sectra (publ) - Performance 26.6% in 12m
SECT-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
71.07%
#6 in Peer-Group
Rel. Strength
75.91%
#1833 in Stock-Universe
Total Return 12m
26.59%
#36 in Peer-Group
Total Return 5y
226.80%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 124 |
| P/E Forward | 71.9 |
| High / Low | SEK |
|---|---|
| 52 Week High | 354.80 SEK |
| 52 Week Low | 220.30 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 30.94 |
| Buy/Sell Signal +-5 | -0.90 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SECT-B (26.6%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: SECT-B vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for SECT-B
| Total Return (including Dividends) | SECT-B | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.32% | 4.35% | 1.11% |
| 3 Months | 25.80% | -6.89% | 5.58% |
| 12 Months | 26.59% | -5.08% | 10.51% |
| 5 Years | 226.80% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | SECT-B | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 46.6% | 65.8% | 69.9% |
| 3 Months | 92.8% | -72% | 69.3% |
| 12 Months | 46% | -62.2% | 43.2% |
| 5 Years | 80.6% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #122 | -4.47% | -1.41% |
| 3 Month | #30 | 35.11% | 19.15% |
| 12 Month | #36 | 33.36% | 14.55% |
| 5 Years | #8 | 117.10% | 56.28% |
FAQs
Does Sectra (publ) (SECT-B) outperform the market?
Yes,
over the last 12 months SECT-B made 26.59%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months SECT-B made 25.80%, while XLV made -6.89%.
Performance Comparison SECT-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SECT-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.4% | -1.4% | 18.7% | 16% |
| US NASDAQ 100 | QQQ | -10.2% | -1.8% | 19.4% | 17% |
| German DAX 40 | DAX | -8.2% | 0.4% | 2.3% | -3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.1% | 0.6% | 16.8% | 15% |
| Hongkong Hang Seng | HSI | -10.9% | -5.4% | -0.4% | -1% |
| India NIFTY 50 | INDA | -8.7% | 1% | 19.7% | 28% |
| Brasil Bovespa | EWZ | -12.7% | -0.8% | -1.5% | 17% |
SECT-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10.1% | -1.8% | 15.9% | 4% |
| Consumer Discretionary | XLY | -9.9% | 1.5% | 28.5% | 9% |
| Consumer Staples | XLP | -10.1% | -0.1% | 17.2% | 20% |
| Energy | XLE | -16.3% | -3.2% | 15.1% | 24% |
| Financial | XLF | -8.8% | 2.3% | 15.8% | 3% |
| Health Care | XLV | -12.3% | -4.7% | 19.1% | 32% |
| Industrial | XLI | -9.4% | -0.7% | 13.1% | 8% |
| Materials | XLB | -9.7% | -1.7% | 17.9% | 27% |
| Real Estate | XLRE | -10.9% | -1.3% | 17.7% | 14% |
| Technology | XLK | -10.7% | -2.3% | 18.3% | 22% |
| Utilities | XLU | -11.8% | -0.9% | 10.3% | 5% |
| Aerospace & Defense | XAR | -9.4% | -6.1% | 1.7% | -16% |
| Biotech | XBI | -10.1% | -8.1% | 29.4% | 34% |
| Homebuilder | XHB | -8.8% | 4.7% | 34.1% | 36% |
| Retail | XRT | -6.5% | -0.2% | 26.6% | 26% |
SECT-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -22.2% | -19.0% | 8.81% | 23% |
| Natural Gas | UNG | -9.6% | 2.3% | 0.4% | 41% |
| Gold | GLD | -14% | -6.5% | -11.5% | -21% |
| Silver | SLV | -9.6% | -11.7% | -0.9% | 4% |
| Copper | CPER | -7.9% | -2% | 3.8% | 18% |
SECT-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -11.9% | -1% | 20.1% | 31% |
| iShares High Yield Corp. Bond | HYG | -10.9% | -0.8% | 15% | 17% |